Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 1/20 | 0.43 |
| ▸ | GPR132 | Q9UNW8 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | CMKLR2 | P46091 | 1/20 | 0.40 |
| ▸ | CMKLR1 | Q99788 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13323784 | 0.82 | ACE (0.52) | RENCYP3A4CTSLCTSBSCN9A | |
| SCHEMBL2367464 | 0.82 | ACE (0.52) | RENCYP3A4CTSLCTSBSCN9A | |
| SCHEMBL23092737 | 0.81 | LMNA (0.44) | CYP3A4SCN9A | |
| SCHEMBL29715367 | 0.81 | LMNA (0.44) | CYP3A4SCN9A | |
| SCHEMBL5205285 | 0.81 | LMNA (0.44) | CYP3A4SCN9A | |
| SCHEMBL22457492 | 0.81 | REN (0.58) | RENCTSLCTSBACE | |
| SCHEMBL24435851 | 0.81 | REN (0.58) | RENCTSLCTSBACE | |
| SCHEMBL3820797 | 0.80 | MMP13 (0.36) | RENCTSLCTSB | |
| SCHEMBL479035 | 0.78 | ACE (0.61) | GPR132CYP3A4CTSLCTSBSCN9A | |
| SCHEMBL479037 | 0.78 | ACE (0.61) | GPR132CYP3A4CTSLCTSBSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1807443-A1 | ACYLATED NONADEPSIPEPTIDES USED AS LYSOBACTIN DERIVATIVES | AiCuris GmbH & Co. KG (DE) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006048139-A1 | ACYLATED NONADEPSIPEPTIDES USED AS LYSOBACTIN DERIVATIVES | AICURIS GMBH & CO. KG (DE) | 2006-05-11 | — | — | WO | disclosed |